» Articles » PMID: 33113558

Local Administration of Carboplatin in Poloxamer 407 After an Ulnar Osteosarcoma Removal in a Dog

Overview
Date 2020 Oct 28
PMID 33113558
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

An 8 yr old male castrated hound presented for a left distal ulnar osteosarcoma. Staging (computed tomography and nuclear scintigraphy) did not reveal any metastases. A limb-sparing ulnectomy with local adjunctive carboplatin in a poloxamer copolymer gel (poloxamer 407) was performed. The patient recovered without complications after surgery. No wound healing complications or adverse effects occurred after local use of carboplatin in poloxamer 407. The local recurrence-free interval was 296 days from surgery, and the survival time was 445 days from initial diagnosis. This is the first report in the veterinary literature of using poloxamer 407 as a carrier for local delivery of chemotherapeutic drugs in a clinical patient.

Citing Articles

Silver nanoparticles can be sampled by ultrafiltration probe but elution into & recovery from plasma and Dulbecco's Phosphate Buffered Saline differs .

Risselada M, McCain R, Bates M, Anderson M PeerJ. 2024; 12:e18388.

PMID: 39465173 PMC: 11512798. DOI: 10.7717/peerj.18388.


Review of local extravascular delivery systems for chemotherapeutic agents in small animals and horses.

Risselada M, Worth D Can Vet J. 2023; 64(10):957-967.

PMID: 37780479 PMC: 10506355.


Nanocarriers in Veterinary Medicine: A Challenge for Improving Osteosarcoma Conventional Treatments.

Sapino S, Chindamo G, Chirio D, Morel S, Peira E, Vercelli C Nanomaterials (Basel). 2022; 12(24).

PMID: 36558354 PMC: 9785518. DOI: 10.3390/nano12244501.